We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+640.53%
AUM
$12B
AUM Growth
-$622M
Cap. Flow
-$298M
Cap. Flow %
-2.48%
Top 10 Hldgs %
21.36%
Holding
837
New
28
Increased
81
Reduced
101
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.83K
2
RY icon
Royal Bank of Canada
RY
+$4.09K
3
RIO icon
Rio Tinto
RIO
+$3.61K
4
AMGN icon
Amgen
AMGN
+$3.58K
5
ARW icon
Arrow Electronics
ARW
+$3.22K

Top Sells

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$35.3M
2
TIF
Tiffany & Co.
TIF
+$27.7M
3
VRNS icon
Varonis Systems
VRNS
+$17.6M
4
OSB
Norbord Inc.
OSB
+$16.7M
5
QEP
QEP RESOURCES, INC.
QEP
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.23%
2 Technology 22.73%
3 Consumer Discretionary 9.47%
4 Financials 7.93%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYTK icon
301
Cytokinetics
CYTK
$10.8B
$7.5M 0.06%
375,853
– –
AERI
302
DELISTED
Aerie Pharmaceuticals
AERI
$7.48M 0.06%
576,495
– –
PSNL icon
303
Personalis
PSNL
$1.55B
$7.43M 0.06%
211,316
-15
-0% -$514
TRI icon
304
Thomson Reuters
TRI
$45.2B
$7.42M 0.06%
89,656
– –
CMG icon
305
Chipotle Mexican Grill
CMG
$40.7B
$7.26M 0.06%
272,450
– –
ENTA icon
306
Enanta Pharmaceuticals
ENTA
$402M
$7.24M 0.06%
178,941
– –
LNG icon
307
Cheniere Energy
LNG
$54.9B
$7.23M 0.06%
125,347
– –
ROP icon
308
Roper Technologies
ROP
$39.9B
$7.06M 0.06%
17,058
– –
TU icon
309
Telus
TU
$15.1B
$7.03M 0.06%
369,843
– –
RY icon
310
Royal Bank of Canada
RY
$293B
$6.96M 0.06%
88,197
+47
+0.1% +$4.09K
SBAC icon
311
SBA Communications
SBAC
$19.2B
$6.89M 0.06%
25,421
– –
BNTX icon
312
BioNTech
BNTX
$23.3B
$6.87M 0.06%
87,761
– –
KEY icon
313
KeyCorp
KEY
$24.3B
$6.84M 0.06%
434,278
– –
CPB icon
314
Campbell Soup
CPB
$6.69B
$6.81M 0.06%
146,723
– –
RCKT icon
315
Rocket Pharmaceuticals
RCKT
$397M
$6.78M 0.06%
128,749
– –
WST icon
316
West Pharmaceutical
WST
$24.8B
$6.7M 0.06%
24,620
– –
FRC
317
DELISTED
First Republic Bank
FRC
$6.69M 0.06%
47,407
– –
ALLY icon
318
Ally Financial
ALLY
$13.3B
$6.66M 0.06%
194,447
– –
TTWO icon
319
Take-Two Interactive
TTWO
$47.4B
$6.65M 0.06%
33,341
– –
ASMB icon
320
Assembly Biosciences
ASMB
$530M
$6.61M 0.06%
94,712
– –
WFC icon
321
Wells Fargo
WFC
$265B
$6.6M 0.05%
227,589
– –
STZ icon
322
Constellation Brands
STZ
$22.8B
$6.59M 0.05%
31,309
– –
KYNB
323
Kyntra Bio
KYNB
$28.2M
$6.58M 0.05%
7,385
– –
AIZ icon
324
Assurant
AIZ
$14.2B
$6.57M 0.05%
50,200
– –
F icon
325
Ford
F
$55.8B
$6.57M 0.05%
777,815
– –
11 12
13
14 15

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return

Candriam SCA's Q1 2021 Portfolio in Review

As of Q1 2021, Candriam SCA held 837 positions worth $12B, down 4.9% from $12.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2021 filing shows 28 new, 81 increased, 101 reduced and 16 closed positions. Its largest new stake was Arrow Electronics: 31 shares worth $3K. The largest sale was New Oriental, an estimated $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q1 2021 buy was Arrow Electronics: 31 shares worth $3K.
  • Candriam SCA added most to AstraZeneca in Q1 2021, an estimated $5.83K increase.
  • Candriam SCA's biggest Q1 2021 reduction was New Oriental, cutting an estimated $35.3M.
  • Candriam SCA fully exited Tiffany & Co. in Q1 2021, selling an estimated $27.7M.
  • Candriam SCA's ten largest holdings make up 21% of its $12B portfolio in Q1 2021.
  • Candriam SCA opened 28 new positions and closed 16 in Q1 2021.
  • Candriam SCA's portfolio value fell 4.9% quarter-over-quarter to $12B.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.